Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
16 /100
LOW RISK
Score updated Aug 28, 2026

KNSA — Kiniksa Pharmaceuticals International, plc Dilution Risk Tracker

Track KNSA dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track KNSA — Get alerts when the score changes →

As of August 28, 2026, Kiniksa Pharmaceuticals International, plc (KNSA) has a DilutionWatch DilutionScore of 16/100, rated LOW dilution risk. Kiniksa Pharmaceuticals International, plc has a market capitalization of $3.72B, 68.44M shares outstanding, 230 institutional holders tracked.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
20
💰Cash Runway
📊 Float Risk
45
⚠️ Warrant Exposure
15
🔄 Convertible Debt
15

Dilution Forecast

☀️
Clear
No significant dilution signals
model est. 0%
No significant dilution signals detected for KNSA.
🔔 Track KNSA — Get forecast alerts →

Market Data

Market Cap$3.72B
Shares Outstanding68.44M
Float40.08M
Cash$468.09M
Debt$9.03M
Short InterestN/A

Institutional Holdings

QoQ: ↑ 0.5% shares (2026Q1 vs prior)
230 institutional holders · 52.50M shares
#1 FMR LLC 6.82M shares
#2 Rubric Capital Management LP 3.75M shares
#3 MORGAN STANLEY 3.72M shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest4.32M
Days to Cover5.0
% of Float10.8%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2018-12-31
4 INSIDER TRANSACTION 2026-05-01
4 INSIDER TRANSACTION 2026-04-30
4 INSIDER TRANSACTION 2026-04-29
4 INSIDER TRANSACTION 2026-04-13
Full SEC filing analysis available with free account

Recent News

No recent news

Factual KNSA Dilution Snapshot

Kiniksa Pharmaceuticals International, plc (KNSA) has a DilutionScore of 16/100, rated Low dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track KNSA Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking KNSA — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for KNSA
KNSA FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.